Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
Bardia A, Hurvitz SA, Tolaney SM, Loirat D, Punie K, Oliveira M, Brufsky A, Sardesai SD, Kalinsky K, Zelnak AB, Weaver R, Traina T, Dalenc F, Aftimos P, Lynce F, Diab S, Cortés J, O'Shaughnessy J, Diéras V, Ferrario C, Schmid P, Carey LA, Gianni L, Piccart MJ, Loibl S, Goldenberg DM, Hong Q, Olivo MS, Itri LM, Rugo HS; ASCENT Clinical Trial Investigators. Bardia A, et al. Among authors: punie k. N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485. N Engl J Med. 2021. PMID: 33882206 Clinical Trial.
Career and Professional Development for Young Oncologists.
Mair MJ, Cardone C, Connolly L, Kfoury M, Lambertini M, Lim J, Mariamidze E, Matikas A, Pihlak R, Punie K, Oing C, Sánchez-Bayona R, Sobczuk P, Zhu H, Berghoff AS, Amaral T. Mair MJ, et al. Among authors: punie k. Oncol Res Treat. 2023;46(3):67-71. doi: 10.1159/000528541. Epub 2022 Dec 6. Oncol Res Treat. 2023. PMID: 36473447 Review.
Young oncologists' perspective on the role and future of the clinician-scientist in oncology.
Lim KHJ, Westphalen CB, Berghoff AS, Cardone C, Connolly EA, Güven DC, Kfoury M, Kocakavuk E, Mandó P, Mariamidze E, Matikas A, Moutafi M, Oing C, Pihlak R, Punie K, Sánchez-Bayona R, Sobczuk P, Starzer AM, Tečić Vuger A, Zhu H, Cruz-Ordinario MVB, Altuna SC, Canário R, Vuylsteke P, Banerjee S, de Azambuja E, Cervantes A, Lambertini M, Mateo J, Amaral T. Lim KHJ, et al. Among authors: punie k. ESMO Open. 2023 Oct;8(5):101625. doi: 10.1016/j.esmoop.2023.101625. Epub 2023 Aug 31. ESMO Open. 2023. PMID: 37659290 Free PMC article. No abstract available.
Breast cancer subtype and survival by parity and time since last birth.
De Mulder H, Laenen A, Wildiers H, Punie K, Poppe A, Remmerie C, Lefrère H, Nevelsteen I, Smeets A, Van Nieuwenhuysen E, Han S, Van Limbergen E, Floris G, Vergote I, Neven P. De Mulder H, et al. Among authors: punie k. Breast Cancer Res Treat. 2018 Jun;169(3):481-487. doi: 10.1007/s10549-018-4701-6. Epub 2018 Feb 10. Breast Cancer Res Treat. 2018. PMID: 29426984
Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer.
Hoste G, Punie K, Wildiers H, Beuselinck B, Lefever I, Van Nieuwenhuysen E, Han SN, Berteloot P, Concin N, Salihi R, Vergote I, Neven P. Hoste G, et al. Among authors: punie k. Breast Cancer Res Treat. 2018 Aug;171(1):131-141. doi: 10.1007/s10549-018-4827-6. Epub 2018 May 16. Breast Cancer Res Treat. 2018. PMID: 29766363
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms.
Saini KS, de Las Heras B, Plummer R, Moreno V, Romano M, de Castro J, Aftimos P, Fredriksson J, Bhattacharyya GS, Olivo MS, Schiavon G, Punie K, Garcia-Foncillas J, Rogata E, Pfeiffer R, Orbegoso C, Morrison K, Curigliano G, Chin L, Saini ML, Rekdal Ø, Anderson S, Cortes J, Leone M, Dancey J, Twelves C, Awada A. Saini KS, et al. Among authors: punie k. JCO Glob Oncol. 2020 Sep;6:1357-1362. doi: 10.1200/GO.20.00346. JCO Glob Oncol. 2020. PMID: 32897732 Free PMC article. No abstract available.
Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes.
Deman F, Punie K, Laenen A, Neven P, Oldenburger E, Smeets A, Nevelsteen I, Van Ongeval C, Baten A, Faes T, Christiaens M, Janssen H, Weltens C, Desmedt C, Wildiers H, Floris G. Deman F, et al. Among authors: punie k. Breast Cancer Res Treat. 2020 Dec;184(3):985-998. doi: 10.1007/s10549-020-05913-x. Epub 2020 Sep 12. Breast Cancer Res Treat. 2020. PMID: 32920743
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.
Mittendorf EA, Zhang H, Barrios CH, Saji S, Jung KH, Hegg R, Koehler A, Sohn J, Iwata H, Telli ML, Ferrario C, Punie K, Penault-Llorca F, Patel S, Duc AN, Liste-Hermoso M, Maiya V, Molinero L, Chui SY, Harbeck N. Mittendorf EA, et al. Among authors: punie k. Lancet. 2020 Oct 10;396(10257):1090-1100. doi: 10.1016/S0140-6736(20)31953-X. Epub 2020 Sep 20. Lancet. 2020. PMID: 32966830 Clinical Trial.
Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Floris G, Richard F, Hamy AS, Jongen L, Wildiers H, Ardui J, Punie K, Smeets A, Berteloot P, Vergote I, De Croze D, Meseure D, Salomon A, Laé M, Reyal F, Biganzoli E, Neven P, Desmedt C. Floris G, et al. Among authors: punie k. J Natl Cancer Inst. 2021 Feb 1;113(2):146-153. doi: 10.1093/jnci/djaa090. J Natl Cancer Inst. 2021. PMID: 33152071 Free PMC article.
103 results